Senores Pharmaceuticals Ltd. NSE: SENORES | BSE: 544319

Senores Pharmaceuticals Live Share Price Today, Share Analysis and Chart

Name: Senores Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Senores Pharmaceuticals Ltd.
Rating: 3.147625
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services.

798.90 -22.20 (-2.70%)

145.2K

NSE+BSE Volume

NSE 17 Dec, 2025 3:59 PM (IST)

Acquisition

Senores Pharma to acquire Apnar Pharma for Rs 91 crore to expand its presence in the UK and Canada See details

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Bullish

70.3 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

988

1Yr Price target upside is 24%

4 analysts

Senores Pharmaceuticals Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Senores Pharmaceuticals Live Share Price Today, Share Analysis and Chart

Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services.

SWOT Analysis

Senores Pharmaceuticals Live Price Chart